Atlas Trials

Haloperidol Versus Ondansetron for Cannabis Hyperemesis Syndrome (HaVOC)

Clinical trial NCT03056482 · COMPLETED

Trial details

NCT number
NCT03056482
Sponsor
Dr. Marco L.A. Sivilotti
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Cannabis Use Disorder
Start date
2017-05-21
Primary completion
2019-06-30
Enrollment
33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.